[Home ] [Archive]   [ فارسی ]  
:: Main :: About us :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
About the Journal
Editorial Board
Advisory Board
Aims & Scope
Journal News
Articles archive::
All Issues
Current Issue
Articles in press
For Authors::
Submission Instruction
For Reviewers::
Reviewers Section
Subscription::
Subscription Form
News& Events::
Journal News
Contact us::
Contact Information
Contact us
Site Facilities::
Site map
Search contents
Top 10 contents
Inform others
Ethics & Permissions::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Indexing
                        
..
:: Volume 16, Issue 2 (Summer 2019) ::
Sci J Iran Blood Transfus Organ 2019, 16(2): 133-148 Back to browse issues page
Heparin induced thrombocytopenia
M. Shahbazi , M. Ahmadinejad
Keywords: Key words: Heparin, Thrombocytopenia, Diagnosis
Full-Text [PDF 558 kb]   (9655 Downloads)     |   Abstract (HTML)  (3656 Views)
Type of Study: Review Article | Subject: Hematology
Published: 2019/07/15
Full-Text:   (22212 Views)
References:
 
 
  1. Franchini M. Heparin-induced thrombocytopenia: an update. Thromb J 2005; 3(1): 14.
  2. Arepally GM. Heparin-induced thrombocytopenia. Blood 2017; 129(21): 2864-72.
  3. Shaikh  N. Heparin Induced Thrombocytopenia: Can Be Excluded. J Blood Disord Transfus 2011: S2. 
  4. Lo GK, Sigouin CS, Warkentin TE. What is the potential for overdiagnosis of heparin-induced thrombocytopenia? Am J Hematol 2007; 82(12): 1037-43.
  5. Levy JH, Hursting MJ. Heparin-induced thrombocytopenia, a prothrombotic disease. Hematol Oncol Clin North Am 2007; 21(1): 65-88.
  6. Dhakal B, Kreuziger LB, Rein L, Kleman A, Fraser R, Aster RH, et al. Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based study. Lancet Haematol 2018; 5(5): e220-e31.
  7. Kelton JG, Warkentin TE. Heparin-induced thrombocytopenia :   a  historical    perspective.   Blood 2008; 112(7): 2607-16.
  8. Greinacher A. Heparin-induced thrombocytopenia. N Engl J Med 2015; 373(3): 252-61.
  9. Warkentin TE, Basciano PA, Knopman J, Bernstein RA. Spontaneous heparin-induced thrombocytopenia syndrome: two new cases and a proposal for defining this disorder. Blood 2014; 123(23): 3651-4.
  10. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 2003; 76(2): 638-48.
  11. Levy JH, Winkler AM. Heparin-induced thrombocytopenia and cardiac surgery. Curr Opin Anaesthesiol 2010; 23(1): 74-9.
  12. Lindhoff-Last E, Gerdsen F, Ackermann H, Bauersachs R. Determination of heparin–platelet factor 4-IgG antibodies improves diagnosis of heparin-induced thrombocytopenia. Br J Haematol 2001; 113(4): 886-90.
  13. Warkentin TE. Platelet count monitoring and laboratory testing for heparin-induced thrombocytopenia: recommendations of the College of American Pathologists. Arch Pathol Lab Med 2002; 126(11): 1415-23.
  14. Junqueira DR, Zorzela LM, Perini E. Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients. Cochrane Database Syst Rev 2017; 4: CD007557.
  15. Krzych Ł, Nowacka E, Knapik P. Heparin-induced thrombocytopenia. Anaesthesiol Intensive Ther 2015; 47(1): 63-76.
  16. Salter BS, Weiner MM, Trinh MA, Heller J, Evans AS, Adams DH, et al. Heparin-induced thrombocytopenia: a comprehensive clinical review. J Am Coll Cardiol 2016; 67(21): 2519-32.
  17. Fathi M. Heparin-induced thrombocytopenia (HIT): Identification and treatment pathways. Glob Cardiol Sci Pract 2018; 2018(2): 15.
  18. Onwuemene O, Arepally GM. Heparin-induced thrombocytopenia: research and clinical updates. Hematology Am Soc Hematol Educ Program 2016; 2016(1): 262-8.
  19. Aster RH. Heparin-induced thrombocytopenia and thrombosis. N Engl J Med 1995; 332(20): 1374-6.
  20. Ahmadinejad M, Shahbazi M, Chegini A, Shamriz R, Ahmadinejad Z. Prevalence of Heparin Induced Thrombocytopenia Among Iranian Patients with Cardiac Surgery. Research and Practice in Thrombosis and Haemostasis 2011; 1: 1366-7.
  21. Lee GM, Arepally GM. Diagnosis and management of heparin-induced thrombocytopenia. Hematol Oncol Clin North Am 2013; 27(3): 541-63.
  22. Warkentin T. Heparin-induced thrombocytopenia. Curr Opin Crit Care 2015 Dec; 21(6): 576-85.
  23. Samhouri Y, Telfah M, Kouides R, Woodlock T. Utilization of 4T score to determine the pretest probability of heparin-induced thrombocytopenia in a community hospital in upstate New York. J Community Hosp Intern Med Perspect 2016; 6(4): 32522.
  24. Farley S, Cummings C, Heuser W, Wang S, Calixte R, Hanna A, et al. Prevalence and overtesting of true heparin-induced thrombocytopenia in a 591-bed tertiary care, teaching hospital. J Intensive Care Med 2019; 34(6): 464-71.
  25. Shahbazi M, Ahmadinejad M, Chegini A. Evaluation of 4T score for possible heparin induced thrombocytopenia diagnosis. Sci J Iran Blood Transfus Organ 2017; 14(4): 272-80. [Article in Farsi]
  26. Favaloro EJ, McCaughan G, Mohammed S, Lau KKE, Gemmell R, Cavanaugh L, et al. HIT or miss? A comprehensive contemporary investigation of laboratory tests for heparin induced thrombocytopenia. Pathology 2018; 50(4): 426-36.
  27. Lo G, Juhl D, Warkentin T, Sigouin C, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost 2006; 4(4): 759-65.
  28. Cuker A, Gimotty PA, Crowther MA, Warkentin TE. Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis. Blood 2012; 120(20): 4160-7.
  29. Piednoir P, Allou N, Provenchère S, Berroeta C, Huisse MG, Philip I, et al. Heparin-induced thrombocytopenia after cardiac surgery: an observational study of 1,722 patients. J Cardiothorac Vasc Anesth 2012; 26(4): 585-90.
  30. Motie M, Kazemzadeh G, Gazeran S. Comparing the incidence of heparin-induced thrombocytopenia (HIT) in patients receiving heparin (UHF) and enoxaparin (LMWH). Biomedical Research 2017; 28(5): 2002-7.
  31. Beigmohammadi M, Hussain Khan Z, Hossein K. Enoxaparin in Suspected Heparin Induce Thrombocytopenia: An Observational Follow-Up in Critically Ill Patients. Biomed J Sci & TecRes 2018; 3(3): 1-5.
  32. Cuker A, Arepally G, Crowther M, Rice L, Datko F, Hook K, et al. The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion. J Thromb Haemost 2010; 8(12): 2642-50.
  33. Pishko AM, Fardin S, Lefler DS, Paydary K, Vega R, Arepally GM, et al. Prospective comparison of HEP score and 4Ts score for the diagnosis of  heparin induced thrombocytopenia. Blood Adv 2018; 2(22): 3155-62.
  34. Demma LJ, Winkler AM, Levy JH. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients. Anesth Analg 2011; 113(4): 697-702.
  35. Otis SA, Zehnder JL. Heparin-induced thrombocytopenia: current status and diagnostic challenges. Am J Hematol 2010; 85(9): 700-6.
  36. Nagler M, Bakchoul T. Clinical and laboratory tests for the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost 2016; 116(5): 823-34.
  37. Favaloro EJ, McCaughan G, Pasalic L. Clinical and laboratory diagnosis of heparin induced thrombocytopenia: an update. Pathology 2017; 49(4): 346-55.
  38. Warkentin TE, Sheppard JA. Testing for heparin-induced thrombocytopenia antibodies. Transfus Med Rev 2006; 20(4): 259-72.
  39. Warkentin  TE,  Arnold  DM,   Nazi  I, Kelton JG. The platelet serotonin-release assay. Am J Hematol 2015; 90(6): 564-72.
  40. Minet V, Dogné JM, Mullier F. Functional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia: A Review. Molecules 2017; 22(4): E617.
  41. Lee DH, Warkentin TE, Denomme GA, Hayward CP, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry. Br J Haematol 1996; 95(4): 724-31.
  42. Scharf RE. Drug that affect platelet function. Semin Thromb Hemost 2012; 38(8): 865-83.
  43. Ahmadinejad M. MD.“Is it Time to Renew the Guidelines for Diagnosis of HIT?”. EC Cardiology 2018; 5: 371-3.
  44. Sun  L,  Gimotty    PA,  Lakshmanan   S,   Cuker     A. Diagnostic accuracy of rapid immunoassays for heparin-induced thrombocytopenia. A systematic review and meta-analysis. Thromb Haemost 2016; 115(5): 1044-55.
  45. Cuker A. Clinical and laboratory diagnosis of heparin-induced thrombocytopenia: an integrated approach.
    Semin Thromb Hemost 2014; 40(1): 106-14.
  46. Leroux D, Hezard N, Lebreton A, Bauters A, Suchon P, de Maistre E, et al. Prospective evaluation of a rapid nanoparticle-based lateral flow immunoassay (STic Expert(®) HIT) for the diagnosis of heparin-induced thrombocytopenia. Br J Haematol 2014; 166(5): 774-82.
  47. Bakchoul T, Zöllner H, Greinacher A. Current insights into the laboratory diagnosis of HIT.  Int J Lab Hematol 2014; 36(3): 296-305.
  48. Cuker A, Cines DB. How I treat heparin-induced thrombocytopenia. Blood 2012; 119(10): 2209-18.
  49. Farm M, Bakchoul T, Frisk T, Althaus K, Odenrick A, Norberg EM, et al. Evaluation of a diagnostic algorithm for Heparin-Induced Thrombocytopenia. Thromb Res 2017; 152: 77-81.
  50. McKenzie SE, Sachais BS. Advances in the pathophysiology and treatment of heparin-induced thrombocytopenia. Curr Opin Hematol 2014; 21(5): 380-7.
  51. Howard-Thompson A, Usery JB, Lobo BL, Finch CK. Heparin-induced thrombocytopenia complicated by warfarin-induced skin necrosis. Am J Health Syst Pharm 2008; 65(12): 1144-7.
  52. Kelton JG, Arnold DM, Bates SM. Nonheparin Anticoagulants for Heparin-Induced Thrombocytopenia. N Engl J Med 2013; 368: 737-44.
 
 
 
 
 
 


 
 
 
 
Sci J Iran Blood Transfus Organ 2019;16(2): 133-148
Review Article
 

 

Heparin induced thrombocytopenia
 
 
Shahbazi M.1, Ahmadinejad M.2
 
 
 
1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
 
 
Abstract
Background and Objectives
Heparin is still a commonly used anticoagulant in prophylaxis and treatment of thromboembolic events. Heparin-induced thrombocytopenia (HIT) is a life-threating adverse drug reaction of heparin. The diagnosis of HIT is made based on two important criteria, firstly clinical evaluation and secondly laboratory testing. In this comprehensive review, the authors will emphasize the risk factors, clinical presentation, pathophysiology, diagnostic principals and treatment of HIT.
 
Materials and Methods
Our study method was based on the search in the PubMed Database by related key words like: "heparin", "heparin induced thrombocytopenia", "pathophysiology", "diagnosis" and “treatment” published during 1997 to 2018.
 
Results
The disease is still a life-threatening event caused by the creation of an antibody against the heparin-PF4 complex and, if platelets are activated, can lead to thrombotic events in patients. Laboratory diagnostic methods are important in excluding or confirming the diagnosis of HIT, especially in patients who are moderate or highly clinical probability of HIT suspected.
 
Conclusions 
Today, with a better understanding of the pathophysiology of the disease as well as the advances made in the speed and precision of laboratory diagnostic methods, an important development has occurred in the diagnosis of HIT.
 
Key words: Heparin, Thrombocytopenia, Diagnosis
 
 
 
 
 
 
 
 
 
 
Received:   1 Jan   2019
Accepted: 12 May 2019
 
 

Correspondence: Ahmadinejad M., MD, Pathologist. Assistant Professor of Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine.
P.O.Box: 14665-1157, Tehran, Iran. Tel: (+9821) 88601599; Fax : (+9821) 88601599
E-mail: minooam@gmail.com                                
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA

XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Shahbazi M, Ahmadinejad M. Heparin induced thrombocytopenia. Sci J Iran Blood Transfus Organ 2019; 16 (2) :133-148
URL: http://bloodjournal.ir/article-1-1240-en.html
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 16, Issue 2 (Summer 2019) Back to browse issues page
فصلنامه پژوهشی خون Scientific Journal of Iran Blood Transfus Organ
The Scientific Journal of Iranian Blood Transfusion Organization - Copyright 2006 by IBTO
Persian site map - English site map - Created in 0.05 seconds with 39 queries by YEKTAWEB 4660